Literature DB >> 19125684

Pathology dynamics predict spinal cord injury therapeutic success.

Cassie S Mitchell1, Robert H Lee.   

Abstract

Secondary injury, the complex cascade of cellular events following spinal cord injury (SCI), is a major source of post-insult neuron death. Experimental work has focused on the details of individual factors or mechanisms that contribute to secondary injury, but little is known about the interactions among factors leading to the overall pathology dynamics that underlie its propagation. Prior hypotheses suggest that the pathology is dominated by interactions, with therapeutic success lying in combinations of neuroprotective treatments. In this study, we provide the first comprehensive, system-level characterization of the entire secondary injury process using a novel relational model methodology that aggregates the findings of approximately 250 experimental studies. Our quantitative examination of the overall pathology dynamics suggests that, while the pathology is initially dominated by "fire-like", rate-dependent interactions, it quickly switches to a "flood-like", accumulation-dependent process with contributing factors being largely independent. Our evaluation of approximately 20,000 potential single and combinatorial treatments indicates this flood-like pathology results in few highly influential factors at clinically realistic treatment time frames, with multi-factor treatments being merely additive rather than synergistic in reducing neuron death. Our findings give new fundamental insight into the understanding of the secondary injury pathology as a whole, provide direction for alternative therapeutic strategies, and suggest that ultimate success in treating SCI lies in the pursuit of pathology dynamics in addition to individually involved factors.

Entities:  

Mesh:

Year:  2008        PMID: 19125684      PMCID: PMC2858296          DOI: 10.1089/neu.2008.0658

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  82 in total

1.  Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord.

Authors:  L Schnell; S Fearn; H Klassen; M E Schwab; V H Perry
Journal:  Eur J Neurosci       Date:  1999-10       Impact factor: 3.386

Review 2.  Clinical trials in spinal cord injury.

Authors:  Andrew R Blight; Mark H Tuszynski
Journal:  J Neurotrauma       Date:  2006 Mar-Apr       Impact factor: 5.269

3.  Review of clinical trials of neuroprotection in acute spinal cord injury.

Authors:  C H Tator; M G Fehlings
Journal:  Neurosurg Focus       Date:  1999-01-15       Impact factor: 4.047

4.  Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury.

Authors:  R D Azbill; X Mu; A J Bruce-Keller; M P Mattson; J E Springer
Journal:  Brain Res       Date:  1997-08-15       Impact factor: 3.252

Review 5.  Critical appraisal of neuroprotection trials in head injury: what have we learned?

Authors:  Christos M Tolias; M Ross Bullock
Journal:  NeuroRx       Date:  2004-01

6.  Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study.

Authors:  D Bartholdi; M E Schwab
Journal:  Eur J Neurosci       Date:  1997-07       Impact factor: 3.386

7.  Geranylgeranylacetone limits secondary injury, neuronal death, and progressive necrosis and cavitation after spinal cord injury.

Authors:  Minoru Fujiki; Yoshie Furukawa; Hidenori Kobayashi; Tatsuya Abe; Keisuke Ishii; Susumu Uchida; Tohru Kamida
Journal:  Brain Res       Date:  2005-08-16       Impact factor: 3.252

8.  Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability.

Authors:  E H Pettus; J T Povlishock
Journal:  Brain Res       Date:  1996-05-25       Impact factor: 3.252

9.  Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

Authors:  M Ankarcrona; J M Dypbukt; E Bonfoco; B Zhivotovsky; S Orrenius; S A Lipton; P Nicotera
Journal:  Neuron       Date:  1995-10       Impact factor: 17.173

10.  Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia.

Authors:  S Krajewski; M Krajewska; L M Ellerby; K Welsh; Z Xie; Q L Deveraux; G S Salvesen; D E Bredesen; R E Rosenthal; G Fiskum; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more
  13 in total

1.  Cargo distributions differentiate pathological axonal transport impairments.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2012-01-25       Impact factor: 2.691

2.  Glial Cell Line-Derived Neurotrophic Factor-Transfected Placenta-Derived Versus Bone Marrow-Derived Mesenchymal Cells for Treating Spinal Cord Injury.

Authors:  Yao Lu; Hui Gao; Man Zhang; Bing Chen; Huilin Yang
Journal:  Med Sci Monit       Date:  2017-04-14

3.  Synaptic glutamate spillover increases NMDA receptor reliability at the cerebellar glomerulus.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2011-08-23       Impact factor: 2.691

4.  An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies.

Authors:  Grant Coan; Cassie S Mitchell
Journal:  Neurodegener Dis       Date:  2015-07-16       Impact factor: 2.977

5.  Undergraduate Biocuration: Developing Tomorrow's Researchers While Mining Today's Data.

Authors:  Cassie S Mitchell; Ashlyn Cates; Renaid B Kim; Sabrina K Hollinger
Journal:  J Undergrad Neurosci Educ       Date:  2015-10-15

6.  Quantitative iTRAQ proteomics reveal the proteome profiles of bone marrow mesenchymal stem cells after cocultures with Schwann cells in vitro.

Authors:  Han Ding; Ang Li; Chao Sun; Jianping Zhang; Jun Shang; Haoshuai Tang; Junjin Li; Min Wang; Xiaohong Kong; Zhijian Wei; Shiqing Feng
Journal:  Ann Transl Med       Date:  2022-09

7.  Syndromics: a bioinformatics approach for neurotrauma research.

Authors:  Adam R Ferguson; Ellen D Stück; Jessica L Nielson
Journal:  Transl Stroke Res       Date:  2011-11-18       Impact factor: 6.829

8.  Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.

Authors:  Cameron W Irvin; Renaid B Kim; Cassie S Mitchell
Journal:  Front Cell Neurosci       Date:  2015-07-01       Impact factor: 5.505

Review 9.  State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.

Authors:  Renaid B Kim; Cameron W Irvin; Keval R Tilva; Cassie S Mitchell
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-05-22       Impact factor: 4.092

10.  Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis.

Authors:  Stephen R Pfohl; Martin T Halicek; Cassie S Mitchell
Journal:  J Neuromuscul Dis       Date:  2015-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.